Hyphens Pharma International Balance Sheet Health
Financial Health criteria checks 5/6
Hyphens Pharma International has a total shareholder equity of SGD69.2M and total debt of SGD7.7M, which brings its debt-to-equity ratio to 11.1%. Its total assets and total liabilities are SGD131.8M and SGD62.6M respectively. Hyphens Pharma International's EBIT is SGD14.3M making its interest coverage ratio -227.2. It has cash and short-term investments of SGD17.9M.
Key information
11.1%
Debt to equity ratio
S$7.69m
Debt
| Interest coverage ratio | -227.2x |
| Cash | S$17.92m |
| Equity | S$69.16m |
| Total liabilities | S$62.59m |
| Total assets | S$131.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1J5's short term assets (SGD101.6M) exceed its short term liabilities (SGD57.7M).
Long Term Liabilities: 1J5's short term assets (SGD101.6M) exceed its long term liabilities (SGD4.9M).
Debt to Equity History and Analysis
Debt Level: 1J5 has more cash than its total debt.
Reducing Debt: 1J5's debt to equity ratio has increased from 1.2% to 11.1% over the past 5 years.
Debt Coverage: 1J5's debt is well covered by operating cash flow (39%).
Interest Coverage: 1J5 earns more interest than it pays, so coverage of interest payments is not a concern.